Fritextsökning
Innehållstyper
-
Top modern lab to Sahlgrenska
The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.
-
Nytt bolagsköp kan vara på gång
Astrazeneca sägs finnas bland budgivarna för Optimer.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Nytt globalt licensavtal för Bactiguard
Bactiguard har ingått ett exklusivt, globalt licensavtal för ortopediska traumaimplantat med Zimmer Biomet.
-
Biomarkörer, salivprov och patientnära tester
Salivprov som kan ersätta urinprov vid spårning av droger, biomarkörer vid bröstcancer och patientnära diagnostiska tester – detta och mycket annat tas upp unde...
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Fusionsrykte kring Astrazeneca och Pfizer
Enligt uppköpsrykten har Pfizer lagt ett bud som värderar Astrazeneca till 665 miljarder kronor. Aktien steg nio procent då börsen öppnade efter påskhelgen.
-
De ska bli framtidens ledare i global hälsa
Åtta forskare har antagits som Sight fellows hos Swedish institute for global health transformation. De ska utvecklas till ledare i FN:s anda.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
De får det svenska storpriset
Cancerforskare får en miljon dollar i prissumma.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Grant for development projects in Gothenburg
Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.
-
Färre USA-resor med nytt samarbete
FDA och Läkemedelsverket ska framöver erkänna varandras inspektioner. – Nu kommer våra resor till USA att minska, säger Lena Björk direktör på Läkemedelsverket.
-
Här är hela listan med de svenska ERC-miljonerna
Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
New nano professor in Denmark
The Technical University of Denmark has appointed a recognized physicist as a new professor of miniaturized sensors.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
Respiratorius hunts millions
The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
BREAKING